Fundraising FoxIMO Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.
BiotechDeep TechHealthtech
Bo Ying(Founder)
Co-investors5Y CapitalCoatue ManagementFuzhou Jiebao Rongan Venture CapitalQiming Venture PartnersSoftBank Vision FundBoyu Capital+7 more
Cobo provides a digital asset custody and wallet platform for institutions such as exchanges, funds, and fintechs, offering custodial, MPC, smart contract, and exchange wallets through unified APIs and SDKs.
Crypto & Web3Enterprise SoftwareFintechHong Kong, HK
Changhao Jiang(Founder)in
Co-investorsBitDAOBN CapitalCyberport Hong KongMantle NetworkA&T CapitalDHVC+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.